entertainment -WSS

entertainment

author：comprehensive 2025-09-30 11:58:35 - browse：57

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： 3 trends to watch in health tech's hiring outlook for 2024

WSS

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Ahead of JPM, here's who's profiting most in health care

J&J to buy cancer drug developer Ambrx Biopharma

Federal weight loss drug coverage is 30 years out of date

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

JPM: CVS says Medicare Advantage patients are impacting profits

leisure time

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Tori Bowie and the unacceptable rates of Black maternal death

Bacterial infection may be ‘key event’ in endometriosis, study says

Continuity nursing helped my family in our darkest PICU moments

3 trends to watch in health tech's hiring outlook for 2024

George Santos makes 1st court appearance after pleading not guilty to 13 counts

When is a doctor not a doctor? Try when patients address women doctors

United colonoscopy coverage change 'may cost lives,' doctors say

PhRMA sues HHS over Medicare drug price negotiation

hotspot

New case study details death in closely watched Alzhiemer's trial

7 people shot in DC, police say

J&J to buy cancer drug developer Ambrx Biopharma

UCB departs biotech trade group BIO

Listen: Biogen's messy board & Laronde's data problem

Morgan Health, with ambitious aims, wants you to know it’s still here

knowledge

explore

hotspot

hotspot